The snake venom peptide Bj-PRO-7a is a M1 muscarinic acetylcholine receptor agonist.

Item

http://www.wikidata.org/entity/Q51771947

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

The snake venom peptide Bj-PRO-7a is a M1 muscarinic acetylcholine receptor agonist.

@en

The snake venom peptide Bj-PRO-7a is a M1 muscarinic acetylcholine receptor agonist.

@nl

type

Item

label

The snake venom peptide Bj-PRO-7a is a M1 muscarinic acetylcholine receptor agonist.

@en

The snake venom peptide Bj-PRO-7a is a M1 muscarinic acetylcholine receptor agonist.

@nl

prefLabel

The snake venom peptide Bj-PRO-7a is a M1 muscarinic acetylcholine receptor agonist.

@en

The snake venom peptide Bj-PRO-7a is a M1 muscarinic acetylcholine receptor agonist.

@nl

P1476

The snake venom peptide Bj-PRO-7a is a M1 muscarinic acetylcholine receptor agonist.

@en

P2093

Antônio C M Camargo

http://www.w3.org/2001/XMLSchema#string

Henning Ulrich

http://www.w3.org/2001/XMLSchema#string

Mirian A F Hayashi

http://www.w3.org/2001/XMLSchema#string

Priscilla D Negraes

http://www.w3.org/2001/XMLSchema#string

Robson L Melo

http://www.w3.org/2001/XMLSchema#string

P2860

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

Characterization of pressure-induced calcium response in neuronal cell lines.

On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis.

Deletion of M1 muscarinic acetylcholine receptors increases amyloid pathology in vitro and in vivo.

Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids.

The discovery of captopril.

Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom.

Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function.

Pharmacological comparison of muscarinic ligands: historical versus more recent muscarinic M1-preferring receptor agonists.

The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development.

P304

77-83

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CYTO.A.20963

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Claudiana Lameu

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46125370

http://www.w3.org/2001/XMLSchema#string

P698

20814884

http://www.w3.org/2001/XMLSchema#string